CASE REPORT
Clinical variability of chromosome 22q11.2 deletion syndrome
 
More details
Hide details
 
Submission date: 2016-03-05
 
 
Final revision date: 2016-06-18
 
 
Acceptance date: 2016-06-22
 
 
Publication date: 2017-12-30
 
 
Cent Eur J Immunol 2017;42(4):412-417
 
KEYWORDS
ABSTRACT
22q11.2 deletion syndrome (22q11.2 DS) is a disorder that has multiple symptoms and affects various organs and systems. Despite the great variability of clinical manifestations, common 22q11.2 DS includes congenital heart defect, immunodeficiency, characteristic facial features, palatal defects, developmental and/or learning disabilities, and hypocalcaemia. We present the cases of three patients with 22q11.2 DS that we have observed. Heart defects were revealed in all cases, and tetralogy of Fallot in one of them. Immune system disorders in these cases were highly variable and did not correlate with aplasia or hypoplasia of the thymus. Cleft palate was diagnosed only in one case. Characteristic facial features were presented in all cases but they were not significant and varied from subtle to mild. Developmental disability was presented by motor delays in two cases. Hypocalcaemia was revealed in one patient, and seizures were absent. Only one case completely fit CATCH-22 syndrome (cardiac defects, abnormal facies, thymic hypoplasia, cleft palate, and hypocalcaemia caused by22q11.2 deletion). The other cases had three out of the five main features, with some other, less significant signs also presented. In some cases, even just a few signs should be the reason for further examination to exclude 22q11.2 deletion syndrome. Currently, immunological disorders are not a significant determinant in the diagnosis of this syndrome, and timely correction of heart defects can reduce the number of recurrent respiratory infections. A multidisciplinary approach to the management of these patients and providing timely, complex medical care will prevent serious complications.
REFERENCES (14)
1.
Guo T, McGinn DM, Blonska A, et al. the International Chromosome 22q11.2 Consortium (2011): Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio- facial/ DiGeorge/ 22q11.2 deletion syndrome patients. Hum Mutat 32: 1278-1289.
 
2.
Kobrynski LJ, Sullivan KE (2007): Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370: 1443-1452.
 
3.
Bassett AS, McDonald-McGinn DM, Devriendt K, et al. (2011): Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 159: 332-339.
 
4.
McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. (2001): Phenotype of the 22q11.2 deletion in individuals identified through an affected relative. Cast a wide FISHing net! Genet Med 3: 23-29.
 
5.
Ryan AK, Goodship JA, Wilson DI, et al. (1997): Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34: 798-804.
 
6.
McDonald-McGinn DM, Kirschner R, Goldmuntz E, et al. (1999): The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 10: 11-24.
 
7.
Digilio MC, Marino B, Capolino R, Dallapiccola B (2005): Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome). Images Paediatr Cardiol 7: 23-34.
 
8.
Butts SC (2009): The facial fenotype of the velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol 73: 343-350.
 
9.
Haclhamdiogˇlu B, Berberogˇlu M, Şlklar Z, et al. (2011): Case report: two patients with partial DiGeorge syndrome presenting with attention disorder and learning difficulties. J Clin Res Pediatr Endocrinol 3: 95-97.
 
10.
Grassi MS, Jacob CM, Kulikowski LD, et al. (2014): Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion. Arq Bras Cardiol 103: 382-390.
 
11.
Sullivan KE (2002): Immunologic issues in VCFS/chromosome 22q11.2 deletion syndrome. Prog Pediatr Cardiol 15: 103-108.
 
12.
Patel K, Akhter J, Kobrynski L, et al.; International DiGeorge Syndrome Immunodeficiency Consortium (2012): Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. J Pediatr 161: 950-953.
 
13.
Swillen A, Vogels A, Devriendt K, Fryns JP (2000): Chromosome 22q11 deletion syndrome: an update and a review of the clinical presentation, the cognitive-behavioral spectrum, and the psychiatric complications. Am J Med Genet 97: 128-135.
 
14.
Cirillo E, Giardino G, Gallo V, et al. (2014): Intergenerational and intrafamilial phenotypic variability in 22q11.2 Deletion syndrome subjects. BMC Medical Genetics 15: 1.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top